INTRODUCTION
The isolation and detection of circulating tumor cells (CTCs), when these are few in number or small in mass, can enable early cancer detection [1] . Currently, most research endeavors to isolate circulating tumor cells rely on antibodies and immunohistochemistry [2, 3] . Aptamer are alternative molecules that have affinities and specificities that are comparable to those of antibodies [4, 5] , but these can be more readily adapted to many applications [6] [7] [8] [9] , including labon-a-chip devices. Here, we report use of a novel epidermal growth factor receptor (EGFR) aptamer biochip to identify and isolate cancer cells that overexpress EGFR. These results provide a solid basis for the development of diagnostic devices that can readily identify and isolate CTCs.
EXPERIMENTAL METHODS
Anti-EGFR aptamers were introduced on a functionalized glass surface. The 3-Aminopropyl triethoxysilane modified surface was activated with 1,4-phenylene diisothiocyanate (PDITC) and unreacted amines of PDITC were capped with 6-amino-1-hexanol, as reported earlier [10] . The biochips without aptamer were used as control. Three different cell types were used: EGFR overexpressed mouse derived tumor cells; Primary human glioblastoma (hGBM) that expressed fluorescent protein (m-cherry); and Meninge derived primary fibroblasts (obtained from rat pups). All biochips were incubated with cell suspension for 30 minutes at 37 °C [11] , and then washed with 1× PBS at 90 rpm for 6-10 minutes. The cells captured on the EGFR aptamer biochip were quantified with imaging. In addition, the cellular interaction between cells and EGFR aptamer attached biochip was closely monitored by time-lapse video [12] .
RESULTS AND DISCUSSION
The number of the attached cells, cell's diameters and densities were analyzed with Image-Pro Plus software. In control groups none or only 1-2 tumor cells could be found. Hydroxyl groups of 6-amino-1-hexanol were available on the surface making it hydrophilic, resulting in a net decrease in the free energy of the surface. These minimized the non-selective physical adsorption of the cells [13, 14] . On the contrary, although the negative charges of aptamer themselves can repel the negatively charged tumor cells (more carboxyl groups cause negative charge surface on the tumor cells) [15, 16] , the tumor cells could bind to the EGFR aptamer and got captured on the surface.
The results are shown in Fig. 1(a,b) . The analysis revealed that the average density of tumor cells on the surface was 392 cell/mm 2 (S.D.: 143.3), and 70.41% of total cells had diameters above 30 µm. The common size of these cells in suspension ranged between 25-30 µm. It showed that aptamers on the surface induced maximum of cell surface EGFR to bind with them. As a result, cells reshaped to cover as large area as possible. Since the results had no difference among 30, 60 and 90 minute incubation groups, incubation for only 30 minutes was done in the subsequent experiments. Temporal images were captured of cell reshaping during the 30 minute incubation period. As Figures 2(a,b) show, many antennas formed and cells reshaped on the surface. In control groups (Figs. 2(c,d) ) cells had only small changes on the hydrophilic surface that repelled the attachment.
In the hGBM cell experiments, the same phenomena were observed. However, the cell density was lower than EGFR overexpressed mouse derived tumor cells, in agreement with relatively less amount of EGFR on hGBM cell surfaces. The difference of average cell densities on 7-day old (stored at -20 °C) and fresh biochips were insignificant, suggesting that the biochip can be stored for long-term, viable for ready-to-use point-of-care clinical examination scenario. In further experiments, fibroblasts and hGBM cells were mixed in a ratio of 1:1 and incubated with biochips. After data calibration, it was seen that the ratio of hGBM and fibroblast
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Proceedings of ASME 2010 First Global Congress on NanoEngineering for Medicine and Biology NEMB2010 February 7-10, 2010 Houston, TX, USA captured cells changed from 1:1 to 9:1, further providing evidence for the isolation and sorting capability of the approach. Fibroblast reshaped from cambiform, stellar or other irregular shapes to spherical (Fig. 3) , putatively to increase the density of aptamer interacting EGFR on cell membrane by increasing contact with surface. These results indicated that aptamer could selectively recognize and isolate tumor cells. 
CONCLUSIONS
The results show that Anti-EGFR aptamer biochip can specifically recognize and capture EGFR overexpressed cancer cells, providing a new modality to detect CTCs from peripheral blood.
